Ipilimumab (3 mg/kg) Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

University of Texas Southwestern Medical Center1
University College, London1

Indications

Cancer2
Liver Disease1
Glioblastoma - Category1
Gliosarcoma, Adult1
Hepatocellular Carcinoma (HCC)1

Other1 trial

A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.

Phase 1

Dallas, Texas1 trial

Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma

University of Texas Southwestern Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.